Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Nov;101(22):1773-5.
doi: 10.1136/heartjnl-2015-308295. Epub 2015 Aug 24.

Comparative effectiveness of cardiac implantable electrical devices

Daniel B Kramer  1 , Laura A Hatfield  2 , Sharon-Lise T Normand  3
Affiliations
Editorial

Comparative effectiveness of cardiac implantable electrical devices

Daniel B Kramer et al. Heart. 2015 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimated HRs and 95% CIs for each treatment (row) versus each contrast treatment (column). The subgroups on each panel”s x axis are defined by gender, age (<60 years, 60+ years), QRS duration (<120 ms, 120–149 ms, 150+ ms) and LBBB (Y=yes, N=no). The colours indicate results from two different samples: the full sample and the reduced sample that omits patients with QRS <120 ms and NYHA class I. This figure reproduces the main results from table 2 and the sensitivity results from table S5 of the Woods et al article. CRT-D, cardiac resynchronisation therapy-defibrillator; CRT-P, CRT-pacemaker; ICD, implantable cardioverter defibrillator; LBBB, left bundle branch block; MT, medical therapy; NYHA, New York Heart Association.
See this image and copyright information in PMC

Comment on

References

    1. Kusumoto FM, Calkins H, Boehmer J, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014;130:94–125. - PubMed
    1. Kramer DB, Matlock DD, Buxton AE, et al. Implantable cardioverter-defibrillator use in older adults: proceedings of a Hartford change AGEnts symposium. Circ Cardiovasc Qual Outcomes. 2015;8:437–46. - PMC - PubMed
    1. Lewis KB, Stacey D, Matlock DD. Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients’ perspectives. Patient. 2014;7:243–60. - PubMed
    1. Woods B, Hawkins N, Mealing S, et al. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart. doi: 10.1136/heartjnl-2015-307634. Published Online First: 12 Aug 2015. - DOI - PMC - PubMed
    1. Pun PH, Al-Khatib SM, Han JY, et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardia death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis. 2014;64:32–9. - PMC - PubMed

Publication types